MADE WITH ALL NATURAL INGREDIENTS
Lactobacillus Rhamnosus Can Help With Digestive Issues
Lactobacillus Rhamnosus gg is an extremely well researched probiotic strain. It was patented in 1985 and there have been numerous studies proving more than 44 health benefits of this good bacteria. Lactobacillus gg, also known as Lactobacillus Rhamnosus gg, has superb intestinal wall adhesion and thus considered a good probiotic for clearing the way for your body’s native friendly bacterial strains. This probiotic is best for stimulating the immune system, fighting allergies and helping people have fewer sick days. Additionally, it also has some digestive benefits for those with digestive issues. You can read more of L rhamnosus benefits below: Decrease leaky gut symptoms, Decrease IBS symptoms, Decrease constipation.
L. Plantarum Has Been Shown to Reduce Gastrointestinal Problems
Probiotics have been shown to restore the microbiome to a more healthful and natural balance in an individual. The probiotic strains L. plantarum 299v and L. reteuri have been shown to reduce gastrointestinal symptoms such as diarrhea, inflammation, overgrowth of pathogenic bacteria and decreased intestinal barrier function. According to Orel, "several Lactobacillus reuteri strains exhibit various characteristics such as secretion of antimicrobial reuterin, production of short-chain fatty acids, down-regulation of inflammatory immune response, and direct influence on enteric nervous system among the others, which render them good candidates for prevention and treatment of various FGIDs". L. rhamnosus GG has been shown to be effective in treating several gastrointestinal disorders such as IBS and is reported to be tolerated well and with no reports of adverse reactions.
Bifidobacterium Breve Raises the Tolerance to Gastric Juices and Acids
In order to reach the gastrointestinal tract in sufficient numbers to exert a therapeutic effect, probiotic bacteria must resist the deleterious actions of low pH, elevated osmolarity and bile salts. Cloning the listerial betaine uptake system, BetL, into the probiotic strain Bifidobacterium breve UCC2003 significantly improved probiotic tolerance to gastric juice and conditions of elevated osmolarity mimicking the gut environment. Furthermore, whilst stable colonization of the murine intestine was achieved by oral administration of B. breve UCC2003, strains harbouring BetL were recovered at significantly higher levels. Finally, in addition to improved gastric transit and intestinal persistence, this approach improved the clinical efficacy of the probiotic culture.